Products - Sleep and sleep conditions | Topic

Showing 6 products

Date | Title

Sleep disordered breathing
Status:
Awaiting development
Expected publication date:
TBC
Tasimelteon for treating sleep disturbance associated with Smith-Magenis syndrome [TSID12191]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Oveporexton for treating type 1 narcolepsy [ID6622]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Orforglipron for treating obstructive sleep apnoea associated with obesity or overweight [ID6706]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
AI technologies to aid the scoring and interpretation of diagnostic sleep studies
Status:
Awaiting development
Programme:
HealthTech guidance
Expected publication date:
TBC
Lemborexan for treating insomnia [TSID12397]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC